Patent assignee · US · COMPANY

Enanta Pharmaceuticals, Inc.

🏢 View company profile →
288Patents
236Active
288Granted
55Portfolio score

Filing activity: Dec 22, 2000 → Feb 22, 2024 · 62 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7635683B2 Quinoxalinyl tripeptide hepatitis C virus inhibitors Human Necessities 64 Active
US8575119B2 2′-chloroacetylenyl substituted nucleoside derivatives Chemistry; Metallurgy 62 Active
US7176208B2 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors Chemistry; Metallurgy 59 Expired
US8101643B2 Benzimidazole derivatives Chemistry; Metallurgy 54 Active
US6680299B2 4'-substituted leucomycins Human Necessities 45 Expired
US7601709B2 Macrocyclic hepatitis C serine protease inhibitors Fixed Constructions 44 Active
US7582605B2 Phosphorus-containing hepatitis C serine protease inhibitors Chemistry; Metallurgy 40 Active
US7273851B2 Tri-peptide hepatitis C serine protease inhibitors Human Necessities 38 Expired
US9085599B2 2′allene-substituted nucleoside derivatives Human Necessities 36 Active
US7125845B2 Aza-peptide macrocyclic hepatitis C serine protease inhibitors Human Necessities 34 Expired
US6809077B2 Cyclosporin analogs for the treatment of autoimmune diseases Human Necessities 33 Expired
US10034893B2 5, 6-D2 uridine nucleoside/tide derivatives Chemistry; Metallurgy 33 Active
US9957281B2 Benzodiazepine derivatives as RSV inhibitors Chemistry; Metallurgy 29 Active
US7605126B2 Acylaminoheteroaryl hepatitis C virus protease inhibitors Chemistry; Metallurgy 29 Active
US6878691B2 6-11 bicyclic ketolide derivatives Human Necessities 27 Expired
US7012065B2 Cyclosporins for the treatment of immune disorders Emerging Cross-Sectional Technologies 25 Expired
US10179131B2 Hepatitis B antiviral agents Chemistry; Metallurgy 25 Active
US7012064B2 Cyclosporins for the treatment of immune disorders Human Necessities 25 Expired
US7368452B2 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors Chemistry; Metallurgy 25 Active
US10358441B2 Processes for the preparation of benzodiazepine derivatives Emerging Cross-Sectional Technologies 25 Active
US10398706B2 Heteroaryldiazepine derivatives as RSV inhibitors Chemistry; Metallurgy 25 Active
US6979671B2 Cyclosporins for the treatment of immune disorders Human Necessities 25 Expired
US10189846B2 Hepatitis B antiviral agents Human Necessities 24 Active
US8846638B2 Macrocyclic nucleoside phosphoramidate derivatives Chemistry; Metallurgy 23 Active
US10428070B2 Hepatitis B antiviral agents Chemistry; Metallurgy 23 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.